drug
TB-500
Preclinicalupdated 3mo agoby PharmaTher Holdings Ltd
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying TB-500
News(4)
- FDA advisory panel narrowly rejects compounding of one peptide, backs two othersRobert F. Kennedy Jr. has lauded peptides and said he takes them himself.stat · 27d ago
- STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and moreIn a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugsstat · 27d ago
- FDA panel endorses broader use of certain peptidesIn a victory for Robert F. Kennedy Jr.’s “MAHA” agenda, panelists narrowly recommended broader use of six of the seven peptides up for consideration despite a lack of substantive evidence supportin…biopharma_dive · 28d ago
- STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptidesThe panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.stat · 28d ago
Data sources
last refreshed 35m ago
Found something off?
comments(0)
5-min edit window · permanent after that